MediSys

Klebsiella

Latest News About - Klebsiella

Filter by countryfromabout

<<10<12345678910>>>10

<<10<12345678910>>>10

Language Selection

For any category/filter, users can choose:

the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

country mentioned in the news item (articles about a country)
country in which the news item was published (articles from a country)

Languages

Select your languages

ar

az

be

bg

bs

ca

cs

da

de

el

en

eo

es

et

fa

fi

fr

ga

ha

he

hi

hr

hu

hy

id

is

it

ja

ka

km

ko

ku

ky

lb

lo

lt

lv

mk

ml

mn

ms

mt

nl

no

pap

pl

ps

pt

ro

ru

rw

se

si

sk

sl

sq

sr

sv

sw

ta

th

tr

uk

ur

vi

zh

all

Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Jose Bengoechea explains: “As the antibiotics we currently use are inefficient at targeting bacteria that live inside our cells, this finding has important clinical implications on how we treat Klebsiella infections,”

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea says: “What we see is a close relationship between Klebsiella’s antibiotic resistance and its virulence, or ability to infect a resistant host,” “These findings emphasise the importance of evaluating both antibiotic resistance and virulence in order to better monitor a patient’s outcome”

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea adds: “I believe this host-directed therapeutic approach will limit the pathogen’s ability to develop resistance against new treatments,” “We already obtained very promising results in animal models in which, without the need for antibiotics, we were able to reduce the infection by more than 80 %”

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea explains: “Interferons activate macrophages and natural killer cells to control Klebsiella pneumonia,” “What this finding means is that interferons could be considered for new therapeutics developments”

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea concludes: “Although we are still at the very early stages, these potential new treatments will have a major health impact, especially considering the increasing number of Klebsiella infections worldwide and the limited treatment options available,”

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

David Coil said: "These kinds of stories are irritating,"

sciencealert Friday, November 30, 2018 1:16:00 AM CET

Paul Matewele said: "If people know about it, they can do something. … They can probably take something like an anti-bacterial cleanser,"

sciencealert Friday, November 30, 2018 1:16:00 AM CET

Paul Matewele spiega: "È contagioso. Se ci si tocca il naso con le dita, poi lo trasferisce sul touchscreen, qualcun'altro lo prende e se ha un taglio aperto in cui entra, allora può essere pericoloso"

ilgiornale Thursday, November 29, 2018 11:40:00 AM CET

Jack Bloom said: "Year after year, we hear that the department is going to be turned around, but we still don’t have a clean audit report,"

iol Tuesday, November 27, 2018 11:41:00 AM CET

Jack Bloom added: "I hope that occupational safety and hygiene risks are tackled effectively at our hospitals and clinics to avoid more disasters,"

iol Tuesday, November 27, 2018 11:41:00 AM CET

Raed Arafat : ”Nu, n-am primit nicio cerere, deci 30 %, estimează colegii de la Iași, dacă este nevoie ne anunță”

stirileprotv Saturday, November 10, 2018 3:32:00 PM CET

Jordi Vila explica: “Tienen una elevada prevalencia en los hospitales, fundamentalmente Klebsiella pneumonia, resistentes a antibióticos de primera, segunda y tercera línea, por lo que la única opción terapéutica que les queda es colistina, que es bastante tóxica. Y aún así ya han aparecido bacterias resistentes a colistina. Necesitamos desesperadamente nuevos antibióticos”

lavanguardia Thursday, November 8, 2018 1:36:00 AM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.

Most active sources for this category

eleconomista-es

Joint Research Centre, Home Affairs, Health and Consumers

ECDC

EFSA